Ticagrelor,a P2Y12 platelet inhibitor, is prescribed for individualswith prior myocardial infarction (MI) or with acute coronary syndrome(ACS) to diminish the risk of future MI, stroke, and cardiovascularmortality. Here, P2RY12 is linked to Stroke.